Original articlesFish, n-3 fatty acids, and cardiovascular haemodynamicsMozaffarian, DariushAuthor Information Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School; and Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, MA Correspondence to Dr Dariush Mozaffarian 665 Huntington Ave, Bldg 2-319, Boston, MA 02115, USA Tel: +617-432-2887; fax: +617-432-2435; e-mail: [email protected] Supported by the National Heart, Lung, and Blood Institute, National Institutes of Health (K08-HL-075628). The author reports no conflicts of interest. Journal of Cardiovascular Medicine: September 2007 - Volume 8 - Issue - p S23-S26 doi: 10.2459/01.JCM.0000289279.95427.e2 Buy Metrics Abstract Consistent evidence indicates that modest consumption of fish or fish oil supplementation lowers the incidence of cardiac death and possibly other cardiovascular events. Precise physiologic mechanisms accounting for such reduced clinical risk are not well understood. Animal-experimental studies, randomized trials, and large observational studies indicate that consumption of fish and marine n-3 polyunsaturated fatty acids (PUFAs) affects cardiac haemodynamics. Independent effects include lowering of systemic vascular resistance (reducing systolic blood pressure by ∼3–5 mmHg and diastolic blood pressure by ∼2–3 mmHg); reduction of resting heart rate (by ∼3 bpm); and improvement of cardiac diastolic filling (by means of potential improvement in both active relaxation and passive compliance). Stroke volume increases, apparently a secondary effect of lower vascular resistance, slower heart rate, and improved filling; direct effects on resting contractility or cardiac output are not evident. These haemodynamic effects could in part account for clinical benefits of fish or fish oil intake, including lower risk of cardiac death and possibly ischaemic stroke, heart failure, cognitive decline, and nonfatal coronary events. © 2007 Italian Federation of Cardiology. All rights reserved.